Looking for something specific?
At 9M India Limited, trust through quality, transparency, performance.
About Pain Management
9M India manufactures a comprehensive range of pain management and analgesic formulations from a WHO-GMP certified facility in Birkoni, Chhattisgarh. Our pain management portfolio spans five dosage forms — tablets, capsules, oral syrups and suspensions, topical formulations (gels, creams and ointments) and sterile injectable analgesics — covering non-opioid analgesics, NSAIDs and combination analgesic formulations across the full spectrum of mild, moderate and acute pain indications.

Pain management medicines represent one of the most demanded categories in both domestic institutional supply and international export markets. Paracetamol — available across tablets, syrups, suspensions and injectable forms — is the single most procured analgesic molecule globally in government and institutional supply programmes. NSAIDs including Ibuprofen, Diclofenac and Ketorolac are manufactured across oral and topical dosage forms, covering both systemic and localised pain management requirements.
Every pain management formulation at 9M India carries a valid DCGI manufacturing licence and is supported by complete regulatory documentation. In-house QC testing covers every batch before release — with COA issued from our own analytical laboratory.
Our Capabilities
From standard tablet compression to topical gel manufacturing and sterile analgesic injection production — our pain management capability covers every dosage form under one WHO-GMP certified roof.
01
Paracetamol tablets in standard, extended-release and dispersible formats — including paediatric dispersible tablets for weight-based dosing. Ibuprofen tablets in film-coated and extended-release formats. Diclofenac tablets in immediate-release, delayed-release (enteric- coated) and sustained-release matrix formats. Combination analgesic tablets — Paracetamol + Ibuprofen, Paracetamol + Diclofenac and other fixed-dose combinations. All tablet formats manufactured with validated dissolution testing confirming in-vitro release performance.
02
Paracetamol syrup and oral suspension in standard and sugar-free variants — including paediatric formulations with age-appropriate concentrations, taste-masking and dosing devices. Ibuprofen oral suspension for paediatric and adult use. These liquid analgesic formulations are among the most demanded items in NHM, district hospital and paediatric institutional supply programmes. Sugar-free variants are manufactured for patients with diabetes and carbohydrate- restricted diets.
03
Diclofenac topical gel and cream for localised musculoskeletal pain — formulated with penetration-enhancing systems for effective transcutaneous delivery. Methyl salicylate + Menthol ointment and cream (counterirritant topical analgesics) for joint and muscle pain. Capsaicin cream for neuropathic and arthritis pain. Diclofenac topical solution for soft tissue and joint inflammation. Topical drug release from gel and cream formulations is validated using Franz diffusion cell methodology.
04
Paracetamol injection (vial liquid) — manufactured in classified cleanroom environments under aseptic conditions with sterility, endotoxin and particulate matter testing on every batch. Ketorolac injection (ampoule) — NSAID injectable for short-term management of moderate to severe acute pain in hospital and post-surgical settings. Diclofenac injection (ampoule) — widely used in institutional supply for acute pain management. All injectable analgesics manufactured as Small Volume Parenterals with full sterility testing and COA from in-house QC laboratory.
05
All pain management formulations are supported by complete documentation for institutional tender submission and export registration — Manufacturing Licence, DCGI approvals, WHO-GMP Certificate, COA, COC, stability data, dissolution profiles and product dossiers. Paracetamol and Ibuprofen formulations are among the most frequently tendered items in government and NHM supply programmes. Our documentation is pre-prepared for bid submission with zero lead time.
Available Dosage Forms
Our analgesic and pain management range is available across every major dosage form — matching the supply requirements of hospital formularies, retail pharmacies, paediatric care programmes and institutional procurement.
Tablets
Capsules
Syrups
Topicals (Gels, Creams & Ointments)
Injections
Why Choose Us
Analgesic medicines are among the most frequently tendered and most competitively sourced categories in institutional procurement. The manufacturer that wins is the one with consistent quality, reliable supply and documentation that holds up at every audit and bid.
Tablets, dispersible tablets, syrups, suspensions, oral solution and sterile injection — all Paracetamol formulations manufactured at 9M India under one WHO-GMP certified quality system. Single-source supply for the world's most procured analgesic.
Non-opioid analgesics (Paracetamol) and NSAIDs (Ibuprofen, Diclofenac, Ketorolac) — across oral solid, oral liquid, topical and injectable dosage forms. No need to split your analgesic portfolio across multiple manufacturers.
Sugar-free Paracetamol syrup, paediatric Ibuprofen suspension and age-appropriate analgesic formulations with validated taste-masking and dosing devices — manufactured and documented for NHM, district hospital and paediatric institutional supply requirements.
Our Pain Management Range
Core analgesic molecules from our manufacturing portfolio — across dosage forms, formulation types and therapeutic pain indications.
Paracetamol Tablet | Analgesic | Standard / ER / Dispersible | Non-opioid analgesic
Paracetamol Syrup | Analgesic | Ready-to-use · Sugar-free | Non-opioid analgesic
Paracetamol Suspension | Analgesic | Paediatric suspension | Non-opioid analgesic
Paracetamol Injection | Analgesic | Vial liquid · Sterile SVP | Non-opioid analgesic
Ibuprofen Tablet | Anti-inflammatory | Film-coated / ER | NSAID
Ibuprofen Suspension | Anti-inflammatory | Paediatric suspension | NSAID
Diclofenac Tablet | Anti-inflammatory | Enteric-coated / SR | NSAID
Diclofenac Gel | Anti-inflammatory | Topical gel | NSAID topical
Diclofenac Injection | Anti-inflammatory | Ampoule · Sterile | NSAID injectable
Ketorolac Injection | Analgesic | Ampoule · Sterile | NSAID injectable
Methyl Salicylate Ointment | Analgesic | Topical ointment | Counterirritant
Capsaicin Cream | Analgesic | Topical cream | Counterirritant
We keep answer short
Frequently asked questions in tablet manufacturing address processes, quality standards, formulation methods, regulatory compliance, and production capabilities, helping clients.
01
9M India manufactures non-opioid analgesics and NSAIDs across five dosage forms — tablets (standard, ER, dispersible), capsules, oral syrups and suspensions, topical gels, creams and ointments, and sterile injectable analgesics. Key molecules include Paracetamol, Ibuprofen, Diclofenac and Ketorolac.
02
Yes. Paracetamol is available in standard tablets, extended-release tablets, dispersible tablets, syrup (standard and sugar-free), oral suspension (standard and paediatric), oral solution and sterile vial injection — all manufactured under one WHO-GMP certified quality system.
03
Yes. Sugar-free Paracetamol syrup, paediatric Paracetamol suspension and paediatric Ibuprofen suspension — with age-appropriate concentrations, taste-masking and calibrated dosing devices. Specifically developed for NHM, district hospital and paediatric institutional supply.
04
Yes. Paracetamol and Ibuprofen formulations are among the most frequently tendered analgesics in government and NHM supply programmes. Our DCGI-approved formulations and pre-prepared documentation package support tender submission with zero lead time.
05
Yes — Diclofenac gel, Diclofenac cream, Diclofenac topical solution, Methyl salicylate ointment and Capsaicin cream. Topical drug release from gel and cream formulations is validated using Franz diffusion cell methodology. Full stability documentation available.
Share your requirement - product availability, documentation and lead times confirmed within 24 hours.